Professional Documents
Culture Documents
Allergic rhinitis
Cause
Allergic rhinitis triggered by the pollens of specific seasonal plants is commonly known as "hay
fever", because it is most prevalent during haying season. However, it is possible to suffer from
hay fever throughout the year. The pollen that causes hay fever varies between individuals and
from region to region; generally speaking, the tiny, hardly visible pollens of wind-pollinated
plants are the predominant cause. Pollens of insect-pollinated plants are too large to remain
airborne and pose no risk. Examples of plants commonly responsible for hay fever include:
Trees: such as pine (Pinus), birch (Betula), alder (Alnus), cedar, hazel (Corylus),
hornbeam (Carpinus), horse chestnut (Aesculus), willow (Salix), poplar (Populus), plane
(Platanus), linden/lime (Tilia) and olive (Olea). In northern latitudes birch is considered
to be the most important allergenic tree pollen, with an estimated 1520% of hay fever
sufferers sensitive to birch pollen grains. A major antigen in these is a protein called Bet
Grasses (Family Poaceae): especially ryegrass (Lolium sp.) and timothy (Phleum
pratense). An estimated 90% of hay fever sufferers are allergic to grass pollen.
The panallergen concept encompasses families of related proteins, which are involved in
general vital processes and thus, widely distributed throughout nature. Plant panallergens
share highly conserved sequence regions, structure, and function. They are responsible for
many IgE cross-reactions even between unrelated pollen and plant food allergen sources.
Although usually considered as minor allergens, sensitization to panallergens might be
problematic as it bears the risk of developing multiple sensitizations. Clinical
manifestations seem to be tightly connected with geographical and exposure factors. Future
population- and disease-based screenings should provide new insights on panallergens and
their contribution to disease manifestations. Such information requires molecule-based
diagnostics and will be valuable for developing patient-tailored prophylactic and
therapeutic approaches. In this article, we focus on profilins, non-specific lipid transfer
proteins, polcalcins, and Bet v 1-related proteins and discuss possible consequences of
panallergen sensitization for the allergic patient. Based on their pattern of IgE crossreactivity, which is reflected by their distribution in the plant kingdom, we propose a novel
classification of panallergens into ubiquitously spread "real panallergens" (e.g. profilins)
and widespread "eurallergens" (e.g. polcalcins). "Stenallergens" display more limited
distribution and cross-reactivity patterns, and "monallergens" are restricted to a single
allergen source.
IgE
Immunoglobulin E (IgE) is a class of antibody (or immunoglobulin (Ig) "isotype") that has
been found only in mammals. IgE exists as monomers consisting of two heavy chains ( chain)
and two light chains, with the chain containing 4 Ig-like constant domains (C1-C4).[1] IgE's
main function is immunity to parasites such as parasitic worms[2] like Schistosoma mansoni,
Trichinella spiralis, and Fasciola hepatica.[3][4][5] IgE may also be important during immune
defense against certain protozoan parasites such as Plasmodium falciparum.[6]
IgE also plays an essential role in type I hypersensitivity,[7] which manifests various allergic
diseases, such as allergic asthma, allergic rhinitis, food allergy, and some types of chronic
urticaria and atopic dermatitis. IgE also plays a pivotal role in allergic conditions, such as
anaphylactic reactions to certain drugs, bee stings, and antigen preparations used in specific
desensitization immunotherapy.
Although IgE is typically the least abundant isotype - blood serum IgE levels in a normal ("nonatopic") individual are only 0.05% of the Ig concentration,[8] compared to 10 mg/ml for the IgGs
(the isotypes responsible for most of the classical adaptive immune response) - it is capable of
triggering the most powerful inflammation reactions.
IgE was discovered in 1966 by the Japanese scientist couple Teruko and Kimishige Ishizaka.[9]
Physiology
There is much speculation into what physiological benefits IgE contributes, and, so far,
circumstantial evidence in animal models and statistical population trends have hinted that IgE
may be beneficial in fighting gut parasites such as Schistosoma mansoni, but this has not been
conclusively proven in humans. It is most likely beneficial in removal of hookworms from the
lung.
Although it is not yet well understood, IgE may play an important role in the immune systems
recognition of cancer,[10] in which the stimulation of a strong cytotoxic response against cells
displaying only small amounts of early cancer markers would be beneficial. If this were the case,
anti-IgE treatments such as omalizumab (for asthma) might have some undesirable side effects.
However, a recent study, which was performed based on pooled analysis using comprehensive
data from 67 phase I to IV clinical trials of omalizumab in various indications, concluded that a
causal relationship between omalizumab therapy and malignancy is unlikely.[11]
Role in disease
Atopic individuals can have up to 10 times the normal level of IgE in their blood (as do sufferers
of hyper-IgE syndrome). However, this may not be a requirement for symptoms to occur as has
been seen in asthmatics with normal IgE levels in their blood - recent research has shown that
IgE production can occur locally in the nasal mucosa.[12]
IgE that can specifically recognise an "allergen" (typically this is a protein, such as dust mite Der
p 1, cat Fel d 1, grass or ragweed pollen, etc.) has a unique long-lived interaction with its highaffinity receptor FcRI so that basophils and mast cells, capable of mediating inflammatory
reactions, become "primed", ready to release chemicals like histamine, leukotrienes, and certain
interleukins. These chemicals cause many of the symptoms we associate with allergy, such as
airway constriction in asthma, local inflammation in eczema, increased mucus secretion in
allergic rhinitis, and increased vascular permeability, it is presumed, to allow other immune cells
to gain access to tissues, but which can lead to a potentially fatal drop in blood pressure as in
anaphylaxis. Although the mechanisms of each response are fairly well understood, why some
allergics develop such drastic sensitivities when others merely get a runny nose is still one of
science's hot topics.
IgE is known to be elevated in various autoimmune disorders such as Lupus(SLE), Rheumatoid
Arthritis(RA) & psoriasis, and is theorized to be of pathogenetic importance in RA and SLE by
eliciting a hypersensitivity reaction. [13][14]
Regulation of IgE levels through control of B cell differentiation to antibody-secreting plasma
cells is thought to involve the "low-affinity" receptor FcRII, or CD23.[15] CD23 may also allow
facilitated antigen presentation, an IgE-dependent mechanism whereby B cells expressing
CD23 are able to present allergen to (and stimulate) specific T helper cells, causing the
perpetuation of a Th2 response, one of the hallmarks of which is the production of more
antibodies.[16]